Weekly Digest – March 2026 Weekly Digest – March 2026 17 March 2026: Voro Therapeutics announced research collaboration with Daiichi Sankyo to advance PrimeBody™ technology for next-generation tumor-activated ADCs Voro Therapeutics has entered a strategic research collaboration with Daiichi Sankyo, […]